These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25684180)

  • 1. Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her-2/neu Expression in Gastric Cancer.
    Cheng Y; Zhou J; Li H
    Clin Transl Sci; 2015 Aug; 8(4):320-5. PubMed ID: 25684180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer.
    Li G; Wang N; Sun C; Li B
    World J Surg Oncol; 2014 Mar; 12():72. PubMed ID: 24678890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of eukaryotic initiation factor 3f is associated with prognosis in gastric carcinomas.
    Cheng Y; Jia C; Li G; Li H
    Oncol Res Treat; 2014; 37(4):198-202. PubMed ID: 24732644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancers.
    Zhou F; Qiu W; Sun L; Xiang J; Sun X; Sui A; Ding A; Yue L
    APMIS; 2013 Jul; 121(7):582-91. PubMed ID: 23489260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
    Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
    Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
    Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
    Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
    He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
    J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
    Liu W; Zhong S; Chen J; Yu Y
    J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of HER-2/neu expression with prognosis of gastric cancer].
    Chen B; Luo RC; Cui F; Qian XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
    Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
    Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer.
    Wu HW; Qin CY; Huang JL; Kong XY; Wang WJ; Bai WK
    Asian Pac J Trop Med; 2014 Apr; 7(4):257-61. PubMed ID: 24507671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu and TOPIIa expression in gastric cancer reflect disease severity.
    Liu HQ; Zhang SL; Song S
    Hepatogastroenterology; 2012 Jun; 59(116):1290-3. PubMed ID: 22281973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ; King BL; Smith BD; Smith GL; DiGiovanna MP; Carter D; Haffty BG
    Clin Cancer Res; 2002 Feb; 8(2):540-8. PubMed ID: 11839675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
    Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial.
    Zhou F; Li N; Jiang W; Hua Z; Xia L; Wei Q; Wang L
    World J Surg Oncol; 2012 Dec; 10():274. PubMed ID: 23249720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
    Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
    PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her-2/neu assessment for gastric carcinoma: validation of scoring system.
    Mrklic I; Bendic A; Kunac N; Bezic J; Forempoher G; Durdov MG; Karaman I; Prusac IK; Pisac VP; Vilovic K; Tomic S
    Hepatogastroenterology; 2012; 59(113):300-3. PubMed ID: 22260838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.